{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:54:35Z","timestamp":1791644075008,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.euf.2016.02.001","type":"journal-article","created":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T13:51:39Z","timestamp":1455976299000},"page":"119-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Phosphodiesterase Type 5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"3","author":[{"given":"Marrissa","family":"Martyn-St James","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kaltenthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kath","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cantrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevan","family":"Wylie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Frodsham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2016.02.001_bib0200","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1464-410X.2008.07755.x","article-title":"An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation","volume":"102","author":"McMahon","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2016.02.001_bib0205","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/00926238908403817","article-title":"Premature ejaculation: clinical subgroups and etiology","volume":"15","author":"Godpodinoff","year":"1989","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.euf.2016.02.001_bib0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/sm2.27","article-title":"An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the Second International Society for Sexual Medicine ad hoc committee for the definition of premature ejaculation","volume":"2","author":"Serefoglu","year":"2014","journal-title":"Sex Med"},{"key":"10.1016\/j.euf.2016.02.001_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/095646206775220540","article-title":"Recommendations for the management of premature ejaculation: BASHH Special Interest Group for Sexual Dysfunction","volume":"17","author":"Richardson","year":"2006","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.euf.2016.02.001_bib0220","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1111\/j.1743-6109.2011.02628.x","article-title":"Does current scientific and clinical evidence support the use of phosphodiesterase type 5 inhibitors for the treatment of premature ejaculation? a systematic review and meta-analysis","volume":"9","author":"Asimakopoulos","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.euf.2016.02.001_bib0225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ijir.2010.34","article-title":"Is there a role for phosphodiesterase type-5 inhibitors in the treatment of premature ejaculation?","volume":"23","author":"Aversa","year":"2011","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.euf.2016.02.001_bib0230","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1345\/aph.1Q008","article-title":"The comparison of combination SSRI and PDE-5 inhibitor therapy to SSRI monotherapy in men with premature ejaculation","volume":"45","author":"Burton","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.euf.2016.02.001_bib0235","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.eururo.2007.08.005","article-title":"The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: a critical analysis of basic science and clinical data","volume":"52","author":"Chen","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2016.02.001_bib0240","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1464-410X.2006.06290.x","article-title":"Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: a systematic review","volume":"98","author":"McMahon","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2016.02.001_bib0245","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.euf.2016.02.001_bib0250","first-page":"1","article-title":"Interventions to treat premature ejaculation: a systematic review short report","volume":"19","author":"Cooper","year":"2015","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.euf.2016.02.001_bib0255","unstructured":"Higgins JPT, Altman DG, Sterne JAC. Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Assessing risk of bias in included studies. In Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 [updated March 2011]. Cochrane Collaboration Web site. http:\/\/handbook.cochrane.org. Accessed 4 January 2016."},{"key":"10.1016\/j.euf.2016.02.001_bib0260","unstructured":"Review Manager (RevMan) [computer program]. Version 5.2. Copenhagen, Denmark: The Nordic Cochrane Centre, The Cochrane Collaboration; 2012."},{"key":"10.1016\/j.euf.2016.02.001_bib0265","first-page":"60","article-title":"Comparison of fluoxetine vs. fluoxetine plus tadalafil in the treatment of premature ejaculation - a double blind, placebo control study","volume":"5","author":"Culha","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.euf.2016.02.001_bib0270","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1439-0272.2008.00910.x","article-title":"Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: a randomised, prospective and crossover study","volume":"41","author":"Mathers","year":"2009","journal-title":"Andrologia"},{"key":"10.1016\/j.euf.2016.02.001_bib0275","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1442-2042.2007.01606.x","article-title":"Can sildenafil treat primary premature ejaculation? A prospective clinical study","volume":"14","author":"Wang","year":"2007","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2016.02.001_bib0280","first-page":"117","article-title":"Combination of sertraline and sildenafil versus sertraline monotherapy in the treatment of acquired premature ejaculation without concomitant diseases","volume":"3","author":"Zhang","year":"2014","journal-title":"Andrology"},{"key":"10.1016\/j.euf.2016.02.001_bib0285","first-page":"20","article-title":"Efficacy and safety of sertraline, viagra and cardura in patients with premature ejaculation","volume":"18","author":"Tang","year":"2004","journal-title":"Chin J Androl"},{"key":"10.1016\/j.euf.2016.02.001_bib0290","first-page":"520","article-title":"Comparison between sildenafil plus sertraline and sertraline alone in the treatment of premature ejaculation","volume":"11","author":"Zhang","year":"2005","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1016\/j.euf.2016.02.001_bib0295","first-page":"203","article-title":"Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with premature ejaculation; prospective, randomized, doubleblind, and placebo-controlled","volume":"9","author":"Lee","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.euf.2016.02.001_bib0300","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.urology.2005.09.002","article-title":"Comparison of efficacy of sildenafil-only, sildenafil plus topical EMLA cream, and topical EMLA-cream-only in treatment of premature ejaculation","volume":"67","author":"Atan","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.euf.2016.02.001_bib0305","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000112607","article-title":"Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study","volume":"80","author":"Mattos","year":"2008","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2016.02.001_bib0310","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1743-6109.2005.20351.x","article-title":"Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation","volume":"2","author":"McMahon","year":"2005","journal-title":"J Sex Med"},{"key":"10.1016\/j.euf.2016.02.001_bib0315","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.aju.2013.05.003","article-title":"On-demand use of tramadol, sildenafil, paroxetine and local anaesthetics for the management of premature ejaculation: a randomised placebo-controlled clinical trial","volume":"11","author":"Gameel","year":"2013","journal-title":"Arab J Urol"},{"key":"10.1016\/j.euf.2016.02.001_bib0320","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000102909","article-title":"Effect of fluoxetine alone and in combination with sildenafil in patients with premature ejaculation","volume":"79","author":"Hosseini","year":"2007","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2016.02.001_bib0325","first-page":"A274","article-title":"The efficacy and safety of combination therapy with tadalafil and serteraline in lifelong premature ejaculation: a randomized double blind study using a validated questionnaire","volume":"21","author":"Mokhtari","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2016.02.001_bib0330","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/and.12289","article-title":"Combination therapy with selective serotonin reuptake inhibitors and phosphodiesterase-5 inhibitors in the treatment of premature ejaculation","volume":"47","author":"Polat","year":"2015","journal-title":"Andrologia"},{"key":"10.1016\/j.euf.2016.02.001_bib0335","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ijir.2009.21","article-title":"Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation","volume":"21","author":"Aversa","year":"2009","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.euf.2016.02.001_bib0340","unstructured":"Questions and answers on Priligy (dapoxetine, 30mg and 60mg tablets). European Medicines Agency Web site. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Priligy_29\/WC500116880.pdf. Dated 20 January 2012."},{"key":"10.1016\/j.euf.2016.02.001_bib0345","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0163-7258(99)00048-0","article-title":"Pharmacokinetics of selective serotonin reuptake inhibitors","volume":"85","author":"Hiemke","year":"2000","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.euf.2016.02.001_bib0350","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00003088-199324030-00003","article-title":"Clinical pharmacokinetics of selective serotonin reuptake inhibitors","volume":"24","author":"van Harten","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.euf.2016.02.001_bib0355","series-title":"Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation","author":"Hatzimouratidis","year":"2015"},{"key":"10.1016\/j.euf.2016.02.001_bib0360","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/S0022-5347(05)64174-2","article-title":"A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation","volume":"168","author":"Salonia","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2016.02.001_bib0365","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1743-6109.2007.00464.x","article-title":"Interrelationships among measures of premature ejaculation: the central role of perceived control","volume":"4","author":"Patrick","year":"2007","journal-title":"J Sex Med"},{"key":"10.1016\/j.euf.2016.02.001_bib0370","doi-asserted-by":"crossref","first-page":"c322","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2016.02.001_bib0375","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1111\/j.1743-6109.2011.02401.x","article-title":"The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation","volume":"8","author":"Jannini","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.euf.2016.02.001_bib0380","unstructured":"Deeks JJ, Higgins JPT, Altman DG. Cochrane Statistical Methods Group. Analysing data and undertaking meta-analyses. In Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 [updated March 2011]. Cochrane Collaboration Web site. http:\/\/handbook.cochrane.org. Accessed 4 January 2016."},{"key":"10.1016\/j.euf.2016.02.001_bib0385","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1743-6109.2007.00696.x","article-title":"Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy","volume":"5","author":"Waldinger","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.euf.2016.02.001_bib0390","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1743-6109.2008.00837.x","article-title":"Clinical trial methodology in premature ejaculation observational, interventional, and treatment preference studies\u2013part II\u2013study design, outcome measures, data analysis, and reporting","volume":"5","author":"McMahon","year":"2008","journal-title":"J Sex Med"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456916000158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456916000158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:47:09Z","timestamp":1762498029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456916000158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S2405456916000158"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2016.02.001","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphodiesterase Type 5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2016.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}